Model DetailsTestis - Leydig cell (Interstitial cell) tumor
Model Name |
Testis - Leydig cell (Interstitial cell) tumor | Strain |
CD-1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
interstitial cell tumor of the testis • testes intersitial cell tumor • testicular interstitial cell tumor • testis, interstitial cell tumor • testis, interstitial-cell tumor • interstitial cell tumor of testis • reproductive tract tumor |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Testis - Leydig cell (Interstitial cell) | Male |
1.5% (1 of 68 mice) |
17-24 months |
|
Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
| Testis - Leydig cell (Interstitial cell) | Male |
2.1% (15 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| Testis - Leydig cell (Interstitial cell) | Male |
0.9% (8 of 891 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Testis - Leydig cell (Interstitial cell) | Male |
0% (0 of 31 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Testis - Leydig cell (Interstitial cell) | Male |
0% (0 of 21 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Testis - Leydig cell (Interstitial cell) | Male |
0% (0 of 52 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |